4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like Patient Dies in Cellectis' Groundbreaking CAR-T Trial, Forcing a Halt to Trials September 4, 2017 NeuroDerm Announces Extraordinary General Meeting Of Shareholders January 26, 2017 Why Theranos Could Burn Through All Its Cash by the End of This Year July 4, 2017
